Sg Americas Securities, LLC Cytokinetics Inc Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 22,203 shares of CYTK stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,203

Previous 138,142 83.93%

Holding current value

$1.14 Million

Previous $7.49 Million 84.34%

% of portfolio

0.0%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$51.22 - $60.16 $5.94 Million - $6.97 Million	-115,939 Reduced 83.93%	22,203 $1.17 Million
Q2 2024 Jul 12, 2024	BUY	$47.86 - $75.05 $6.18 Million - $9.69 Million	129,057 Added 1420.55%	138,142 $7.49 Million
Q1 2024 May 06, 2024	SELL	$63.75 - $108.06 $897,153 - $1.52 Million	-14,073 Reduced 60.77%	9,085 $637,000
Q4 2023 Jan 12, 2024	SELL	$26.88 - $83.49 $32,820 - $101,941	-1,221 Reduced 5.01%	23,158 $1.93 Million
Q3 2023 Oct 13, 2023	BUY	$29.46 - $36.61 $718,205 - $892,515	24,379 New	24,379 $718,000
Q1 2023 Apr 28, 2023	BUY	$33.36 - $45.71 $1.44 Million - $1.97 Million	43,156 Added 1233.73%	46,654 $1.64 Million
Q4 2022 Feb 02, 2023	SELL	$35.77 - $51.11 $74,866 - $106,973	-2,093 Reduced 37.44%	3,498 $160,000
Q3 2022 Oct 31, 2022	SELL	$38.54 - $54.52 $139,938 - $197,962	-3,631 Reduced 39.37%	5,591 $271,000
Q2 2022 Jul 29, 2022	SELL	$33.93 - $48.92 $1.37 Million - $1.98 Million	-40,422 Reduced 81.42%	9,222 $362,000
Q1 2022 Apr 29, 2022	SELL	$29.74 - $46.0 $421,029 - $651,222	-14,157 Reduced 22.19%	49,644 $1.83 Million
Q4 2021 Feb 07, 2022	SELL	$34.35 - $46.38 $107,446 - $145,076	-3,128 Reduced 4.67%	63,801 $2.91 Million
Q3 2021 Nov 01, 2021	BUY	$18.54 - $35.74 $929,818 - $1.79 Million	50,152 Added 298.93%	66,929 $2.39 Million
Q2 2021 Aug 12, 2021	SELL	$19.79 - $26.99 $70,729 - $96,462	-3,574 Reduced 17.56%	16,777 $332,000
Q1 2021 May 13, 2021	SELL	$18.57 - $25.68 $198,810 - $274,930	-10,706 Reduced 34.47%	20,351 $473,000
Q4 2020 Feb 04, 2021	SELL	$15.26 - $28.61 $31,420 - $58,907	-2,059 Reduced 6.22%	31,057 $645,000
Q3 2020 Nov 09, 2020	BUY	$20.58 - $28.96 $349,633 - $492,001	16,989 Added 105.35%	33,116 $717,000
Q2 2020 Jul 20, 2020	SELL	$11.15 - $24.64 $352,752 - $779,535	-31,637 Reduced 66.24%	16,127 $380,000
Q1 2020 Apr 30, 2020	BUY	$8.75 - $16.3 $417,935 - $778,553	47,764 New	47,764 $563,000
Q4 2019 Jan 28, 2020	SELL	$7.95 - $11.84 $116,928 - $174,142	-14,708 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$10.82 - $14.25 $159,140 - $209,589	14,708 New	14,708 $167,000
Q2 2019 Jul 29, 2019	SELL	$7.95 - $11.25 $148,203 - $209,722	-18,642 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$5.95 - $10.19 $110,919 - $189,961	18,642 New	18,642 $151,000
Q4 2017 Jan 24, 2018	SELL	$7.25 - $15.65 $67,860 - $146,484	-9,360 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$12.0 - $15.0 $112,320 - $140,400	9,360	9,360 $136,000

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

126M

Call Options Held

3.29M

Put Options Held

2.01M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.85B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Cytokinetics Inc Transaction History